Luminex Unveils 'Aries' MDx System, Initial Test Menu at AMP Meeting | GenomeWeb

This article was originally published on Nov. 15.

PHOENIX, Ariz. — Luminex this week unveiled its cartridge-based, sample-to-answer molecular diagnostics platform and revealed its initial planned in vitro diagnostic test menu for the new system.

Specifically, Luminex hopes to commercially launch assays for Clostridium difficile, herpes simplex virus I and II, and combined influenza A/influenza B/respiratory syncytial virus in Europe in the second half of 2014 and in the US, assuming regulatory clearance, in early 2015.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.